Best Stocks to Buy Today : Stratzy's call on Strides Pharma Sci - April 03

Stratzy's buy call on Strides Pharma Sci, with a target price of Rs 950, represents an upside potential of approximately 13.7%. As of April 03, the current market price of Strides Pharma Sci stood at Rs 835.05. This call suggests that investors may find value in the stock at current levels and could potentially benefit from a price appreciation towards the target price.

About Strides Pharma Sci:

Strides Pharma Science Limited is a global pharmaceutical company headquartered in India. It develops, manufactures, and markets generic injectables, sterile ophthalmic products, and other dosage forms in over 100 countries. The company's portfolio includes antibiotics, anti-infective, anti-retroviral, oncology, and cardiovascular drugs. Strides has a global manufacturing network with plants in India, Brazil, China, Italy, and the United States. It employs over 12,000 people worldwide and has a strong presence in emerging markets.

52 Week Price Trend:

Strides Pharma Science (STAR), currently trading at Rs 835.05, has experienced significant growth over the past 52 weeks. The stock has reached a peak of Rs 838.6, indicating an impressive upward trajectory. However, it has also faced challenges, with a 52-week low of Rs 268.15. This wide range highlights the company's volatility, potentially offering both opportunities and risks to investors. The stock's current price suggests a strong performance but remains within the range it has fluctuated in over the past year.

Stratzy's MOST Analysis:

With a BB- rating from Stratzy's MOST Framework, STAR's fundamental risks are considered medium. This assessment is based on four pillars: Management, Outlook, Safety, and Trend. STAR's management may be rated as effective, the outlook for the company may be viewed as promising, its financial position may be considered stable, and the industry trend may be seen as favorable. However, some concerns may exist, leading to a BB- rating, indicating the need for cautious monitoring and further analysis to fully understand the company's risk profile.

Fundamental and Technical information provided in this blog were last updated on 03 Apr, 2024

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.